Navigation Links
At Six Months Post-Launch, Neurologist-Reported Patient Share for Tecfidera Among Relapsing-Remitting Multiple Sclerosis Patients Already Rivals that of Gilenya
Date:12/10/2013

ost common reason for Tecfidera discontinuation, as findings suggest that gastrointestinal events are more disruptive to treatment than flushing. Additionally, prescribers report that significantly more patients discontinued Tecfidera due to cost issues compared with three months ago. Neurologists continue to identify cost and managed care issues among the main obstacles to using Tecfidera more, potentially driven by the significant increase in Tecfidera prescription denials by managed care companies for treatment-naive and switched patients. During qualitative interviews, neurologists, while identifying treatment-naive patients among the most likely candidates for Tecfidera, often reported difficulty getting Tecfidera approved as a first-line agent.

"Even with potential access issues, uptake among current nonprescribers and continued use among prescribers will help drive significant growth in Tecfidera patient share to a forecasted 18 percent over the next six months,"  said BioTrends Research Group Senior Business Insights Analyst Emma Williams, Ph.D. "Together with the slight, yet significant, increase in patient shares for Aubagio and Gilenya, oral DMT share is expected to expand to one-third of the market, stealing share from the platform mainstays including Biogen Idec's Avonex, Bayer HealthCare's Betaseron, Teva's Copaxone, and Pfizer/EMD Serono's Rebif, signaling the evolution of the MS treatment algorithm away from injectable drugs."

About BioTrends Research Group
BioTrends Research Group provides syndicated and custom primary market research to pharmaceutical manufacturers competing in clinically evolving, specialty pharmaceutical markets. For information on BioTrends publications and research capabilities, please visit www.bio-trends.com. BioTrends is a Decision Resources Group company.

About Decision Resources Group
Decision Resources Group is a cohe
'/>"/>

SOURCE BioTrends Research Group
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Verenium Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2011
2. China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2012
3. New silk technology preserves heat-sensitive drugs for months without refrigeration
4. Verenium Reports Financial Results For The Second Quarter And Six Months Ended June 30, 2012
5. Origin Agritech Limited Reports Unaudited Third Quarter Financial Results For Three Months Ended June 30, 2012
6. Insmed Announces Financial Results For Second Quarter And Six-months Ended June 30, 2012
7. New technology delivers sustained release of drugs for up to 6 months
8. Cord Blood America Announces 3rd Quarter and Nine Months 2012 Financial Results
9. Origin Agritech Limited Reports Unaudited First Quarter Financial Results For Three Months Ended December 31, 2012
10. Pharmacyclics Reports Results for Six and Three Months Ended December 31, 2012
11. China Cord Blood Corporation to Report Third Quarter and First Nine Months of Fiscal 2013 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)... October 30, 2014 James Sherley says he ... adult tissue stem cell technology since his days as a ... Philadelphia in the late 1990’s. Sherley founded the ASCTC ... company holds all the intellectual property developed in Sherley’s research ... the Massachusetts Institute of Technology (MIT), and more recently as ...
(Date:10/30/2014)... Khaimah, UAE (PRWEB) October 30, 2014 Grace ... of Dr. James A. Manganello, Chairman of the Board, to ... The Bahamas. The appointment was made by the Ministry ... on September 24th, 2014. , More than a ... and Research Bill , Prime Minister Perry Christie said the ...
(Date:10/30/2014)... in the development of quantum technologies has been proposed ... published today (28 October) in Nature Communications , ... a new type of flexibly designed microscopic trap for ... and specialised superfast computers, often depend on harnessing the ... these tiny particles are hugely problematic because of the ...
(Date:10/27/2014)... , October 27, 2014 ... right to produce, exhibit and sell its artificial ... to impeach their patent.      (Photo: ... four years of fighting, the definitive judgement has ... and produces innovative and accessible hi-tech prostheses with ...
Breaking Biology Technology:Boston’s Adult Stem Cell Technology Center, LLC Introduces A New Technology for Monitoring Previously Elusive Adult Stem Cells 2Boston’s Adult Stem Cell Technology Center, LLC Introduces A New Technology for Monitoring Previously Elusive Adult Stem Cells 3Boston’s Adult Stem Cell Technology Center, LLC Introduces A New Technology for Monitoring Previously Elusive Adult Stem Cells 4Grace Century’s Stem Cell Biobank Project Announces Chairman’s Appointment to National Stem Cell Ethics Committee of The Bahamas 2Grace Century’s Stem Cell Biobank Project Announces Chairman’s Appointment to National Stem Cell Ethics Committee of The Bahamas 3Italian Lower Limb Prosthesis Company Wins Lawsuit Against German Giant Ottobock 2
... PharmaNet Development Group, Inc., a leading provider of clinical development services to ... participation at several international professional meetings during the month of June. ... Drug Information Association (DIA) Annual Meeting, ... ...
... ... The use of codon optimization in gene synthesis has long been ... been awarded two US patents covering the technology. DNA2.0,s approach goes beyond ... gene optimization. The algorithm associated with this patent has been proven to ...
... the momentum of their previous events, the Stem Cell ... Stem Cell Awareness Rally in Denver, Colorado on June ... Florida, drew past and prospective patients, news media, U.S. ... public interested in learning more about stem cell treatment. ...
Cached Biology Technology:PharmaNet Development Group Clinical Research Experts to Present at Global Professional Meetings in June 2DNA2.0 Awarded US Patents for Breakthrough Gene Optimization Technology -- Company's Unique Algorithm Enables Expression Yields up to 50 Times Greater than Competing Approaches 2DNA2.0 Awarded US Patents for Breakthrough Gene Optimization Technology -- Company's Unique Algorithm Enables Expression Yields up to 50 Times Greater than Competing Approaches 3Colorado Stem Cell Awareness Rally to Take Place in Denver, Colorado on June 13th, 2009 2Colorado Stem Cell Awareness Rally to Take Place in Denver, Colorado on June 13th, 2009 3
(Date:10/28/2014)... Europe and China have published a paper in the ... that reveals important details about key transitions in the ... and exotic algae, mosses, ferns, trees and flowers growing ... we eat and the ornamental plants adorning our homes, ... years of history., "Our study generated DNA sequences from ...
(Date:10/28/2014)... moving activity in a novel environment are linked ... to an experimental study completed at the University ... Fisheries Research Institute. The study used novel, long-term ... angling trials to analyse if behaviours predict the ... traditional and enriched hatchery rearing environments. Based ...
(Date:10/27/2014)... have delivered a scientific one-two punch with a pair ... via their sticky ends. , Collagen is the most ... and the fibrous tissues that support cells and hold ... synthetic collagen for tissue engineering and cosmetic and reconstructive ... been studying synthetic collagen for a decade, teasing out ...
Breaking Biology News(10 mins):New study uses DNA sequences to look back in time at key events in plant evolution 2New study uses DNA sequences to look back in time at key events in plant evolution 3Fish 'personality' linked to vulnerability to angling 2'Sticky' ends start synthetic collagen growth 2'Sticky' ends start synthetic collagen growth 3
... the subtext of a novel, the human genome sequence ... of A, C, T and G. Since DNA is ... genome sequences among individuals also holds clues to ancestry. ... sequence variations to diseases are very common nowadays. But ...
... - Discovery that a specific gene is integral to both ... toxin in the kernels may lead to ways to control ... the fungal gene ZFR1 and found that it is vital ... Production of the toxin decreased when the scientists disabled the ...
... 2008 -- Exposure to levels of radon gas typically found ... risk of developing lung cancer by as much as 60 ... issue of the journal Health Physics. The finding differs significantly ... of low-level radon exposure, which have detected a slightly elevated ...
Cached Biology News:Multi-institutional study identifies new form of inherited risk of cancer 2Defining gene's role may lead to prevention of dangerous corn toxin 2Defining gene's role may lead to prevention of dangerous corn toxin 3Exposure to low levels of radon appears to reduce the risk of lung cancer, new study finds 2Exposure to low levels of radon appears to reduce the risk of lung cancer, new study finds 3Exposure to low levels of radon appears to reduce the risk of lung cancer, new study finds 4
IHC Polymer Detection Kit (Rabbit DAB)150 slides...
...
Bovine Serum...
Healthy animals 10-32 weeks of age, mixed gender and breed; collected on wet ice following USDA guidelines, using Alsevers solution at 1:2 dilution...
Biology Products: